Agree. This adds more credibility to the multiple applications for B. It should draw the attention of BPs even more. We already have B alone then to have two more applications in a short period of time will have them very interested. Could be part of the strategy of getting partners interested sooner as they don't want to miss the opportunity of this platform and potentially others in the portfolio.
(3)
(0)
Innovation Pharmaceuticals Inc (IPIX) Stock Research Links